View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 21, 2019

PatientPoint partners with Antidote to boost clinical trial enrolment

PatientPoint, a patient engagement solutions provider, has collaborated with digital health company Antidote Technologies to improve clinical trial recruitment using point-of-care patient engagement tools.

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

As part of the alliance, PatientPoint will direct patients and providers at more than 7,300 primary care and subspecialty practices in the US to Antidote’s digital clinical trial search tool called Antidote Match.

Antidote’s technology, which involves a short questionnaire, uses medical ontologies to provide patients with an easy approach to find and connect with medical research.

Currently, the technology powers clinical trials search on more than 250 partner websites.

Antidote Technologies CEO Laurent Schockmel said: “Partnering with PatientPoint is a natural extension of our mission to accelerate breakthroughs in potentially life-saving treatments by bridging the gap between medical research and the people who need it.

“By extending our reach to the point of care, we will meet patients and their trusted providers where they are and when they are primed to act. This will drive trial enrolment and ultimately get next-generation treatments to patients who need them sooner.”

The partners intend to reach out to patients and providers in waiting rooms, exam rooms and the physician back office. They aim to drive doctor-patient discussion and in turn trial participation rates.

PatientPoint founder and CEO Mike Collette said: “When research comes to a standstill, so does the development of tomorrow’s therapies that patients desperately need today.

“Our partnership with Antidote is designed to help reverse that trend by harnessing the influence of the physician and the power of patient-provider discussions to drive interest and enrolment in clinical trials.”

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena